MTHFD1
C-1-tetrahydrofolate synthase, cytoplasmic
Also known as: C1TC_HUMAN, MTHFC, MTHFD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11586
- Gene
- MTHFD1
- Ensembl
- ENSG00000100714
- Chromosome
- 14
- Canonical length
- 935 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
935 residues, UniProt reviewed canonical sequence.
>P11586|MTHFD1
1 MAPAEILNGK EISAQIRARL KNQVTQLKEQ VPGFTPRLAI LQVGNRDDSN LYINVKLKAA
61 EEIGIKATHI KLPRTTTESE VMKYITSLNE DSTVHGFLVQ LPLDSENSIN TEEVINAIAP
121 EKDVDGLTSI NAGKLARGDL NDCFIPCTPK GCLELIKETG VPIAGRHAVV VGRSKIVGAP
181 MHDLLLWNNA TVTTCHSKTA HLDEEVNKGD ILVVATGQPE MVKGEWIKPG AIVIDCGINY
241 VPDDKKPNGR KVVGDVAYDE AKERASFITP VPGGVGPMTV AMLMQSTVES AKRFLEKFKP
301 GKWMIQYNNL NLKTPVPSDI DISRSCKPKP IGKLAREIGL LSEEVELYGE TKAKVLLSAL
361 ERLKHRPDGK YVVVTGITPT PLGEGKSTTT IGLVQALGAH LYQNVFACVR QPSQGPTFGI
421 KGGAAGGGYS QVIPMEEFNL HLTGDIHAIT AANNLVAAAI DARIFHELTQ TDKALFNRLV
481 PSVNGVRRFS DIQIRRLKRL GIEKTDPTTL TDEEINRFAR LDIDPETITW QRVLDTNDRF
541 LRKITIGQAP TEKGHTRTAQ FDISVASEIM AVLALTTSLE DMRERLGKMV VASSKKGEPV
601 SAEDLGVSGA LTVLMKDAIK PNLMQTLEGT PVFVHAGPFA NIAHGNSSII ADRIALKLVG
661 PEGFVVTEAG FGADIGMEKF FNIKCRYSGL CPHVVVLVAT VRALKMHGGG PTVTAGLPLP
721 KAYIQENLEL VEKGFSNLKK QIENARMFGI PVVVAVNAFK TDTESELDLI SRLSREHGAF
781 DAVKCTHWAE GGKGALALAQ AVQRAAQAPS SFQLLYDLKL PVEDKIRIIA QKIYGADDIE
841 LLPEAQHKAE VYTKQGFGNL PICMAKTHLS LSHNPEQKGV PTGFILPIRD IRASVGAGFL
901 YPLVGTMSTM PGLPTRPCFY DIDLDPETEQ VNGLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTHFD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 319 nTPM
Expression across tissuesHPA
Tissue
- liver: 319 nTPM
- tongue: 57 nTPM
- skeletal muscle: 55 nTPM
- adipose tissue: 50 nTPM
- kidney: 50 nTPM
- thymus: 26 nTPM
Single-cell type
- hepatocytes: 199 nCPM
- cardiomyocytes: 152 nCPM
- adipocytes: 125 nCPM
- erythrocyte progenitors: 114 nCPM
- epicardial cells: 102 nCPM
- myonuclei: 81 nCPM
Immune cell
- memory B-cell: 25 nTPM
- intermediate monocyte: 19 nTPM
- T-reg: 18 nTPM
- myeloid DC: 17 nTPM
- NK-cell: 17 nTPM
- non-classical monocyte: 16 nTPM
Brain region
- choroid plexus: 20 nTPM
- basal ganglia: 17 nTPM
- hippocampal formation: 14 nTPM
- cerebral cortex: 12 nTPM
- hypothalamus: 10 nTPM
- midbrain: 9.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTHFD1.
Disease | AllUniProt
Conditions MTHFD1 is implicated in, by any mechanism.
- Neural tube defects, folate-sensitive (NTDFS) MIM:601634
- Colorectal cancer (CRC) MIM:114500
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) MIM:617780
Disease | GeneticClinVar
40 pathogenic / likely-pathogenic of 663 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia
- Neural tube defects, folate-sensitive
- Severe combined immunodeficiency disease
- MTHFD1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 10-formyltetrahydrofolate biosynthetic process
- embryonic neurocranium morphogenesis
- embryonic viscerocranium morphogenesis
- folic acid metabolic process
- heart development
- methionine biosynthetic process
- methionine metabolic process
- neural tube closure
- neutrophil homeostasis
- purine nucleotide biosynthetic process
- somite development
- tetrahydrofolate interconversion
- transsulfuration
- purine ribonucleotide biosynthetic process
Molecular functions
- ATP binding
- formate-tetrahydrofolate ligase activity
- methenyltetrahydrofolate cyclohydrolase activity
- methylenetetrahydrofolate dehydrogenase (NADP+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Formate-tetrahydrofolate ligase, FTHFS
- Tetrahydrofolate dehydrogenase/cyclohydrolase
- Formate-tetrahydrofolate ligase, FTHFS, conserved site
- Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain
- Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain
- Tetrahydrofolate dehydrogenase/cyclohydrolase, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- NAD(P)-binding domain superfamily
- Aminoacid dehydrogenase-like, N-terminal domain superfamily
- Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain
- Formate--tetrahydrofolate ligase
- Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTHFD1 as an antibody target. Whether an autoantibody or antibody against MTHFD1 could matter depends on whether native MTHFD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTHFD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTHFD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...